1.
Shabana Mohammad Ali. Safety of Dapagliflozinin Reducing Cardiac Events and Deaths among NYHA Class II and III Cardiac Failure Patients. Pakistan Journal of Medical & Health Sciences [Internet]. 2024 Apr. 19 [cited 2024 Sep. 8];18(01):35. Available from: https://mail.pjmhsonline.com/index.php/pjmhs/article/view/5440